TABLE 2.
Therapeutics |
Vaccine |
||||||||||||
Diagnostic Reagenta |
Antibodyb |
Otherc |
Soluble Antigend |
VLPe |
|||||||||
Number | Kg | Number of | Kg | Kg | Number | Kg | Kg | ||||||
of tests | LFW | m2 | persons treated | LFW | m2 | LFW | m2 | of doses | LFW | m2 | LFW | m2 | |
Mar | 483,623 | 1.25 | 1.67 | 10,376 | 153334 | 204445 | 40983 | 54644 | 3,6 × 107 | 20696 | 27592 | 9388 | 12518 |
Apr | 847,933 | 2.19 | 2.92 | 9,967 | 147297 | 196396 | 39370 | 52493 | |||||
May | 2,523,838 | 6.52 | 8.69 | 2,756 | 40723 | 54298 | 10885 | 14513 | |||||
Jun | 1,435,880 | 3.71 | 4.95 | 729 | 107775 | 14367 | 2880 | 3840 |
aAmount per test: 100 ng × 2, b9 g per dose, c3 g per dose, d40 μg per dose, e120 μg per dose.